⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28777937 | 0.59 | — | — | |
| Methylisothiocyanate SCHEMBL3152 | 0.56 | — | — | |
| SCHEMBL452053 | 0.56 | — | — | |
| SCHEMBL9617070 | 0.56 | — | — | |
| SCHEMBL344363 | 0.56 | — | — | |
| SCHEMBL2439268 | 0.56 | — | — | |
| SCHEMBL1534324 | 0.56 | — | — | |
| SCHEMBL14164129 | 0.56 | — | — | |
| SCHEMBL1176563 | 0.56 | — | — | |
| SCHEMBL8008548 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055475-A1 | COMPOSITIONS AND METHODS FOR DETECTING MONKEYPOX VIRUS | ROCHE MOLECULAR SYSTEMS INC (US) | 2026-02-26 | — | — | US | claimed |
| EP-4577674-A1 | COMPOSITIONS AND METHODS FOR DETECTING MONKEYPOX VIRUS | F. Hoffmann-La Roche AG (CH) | 2025-07-02 | — | — | EP | claimed |
| CN-118171846-A | GIS-based transformer substation extension planning method | 广东电网有限责任公司广州供电局 | 2024-06-11 | — | — | CN | claimed |
| WO-2024042042-A1 | COMPOSITIONS AND METHODS FOR DETECTING MONKEYPOX VIRUS | F. HOFFMANN-LA ROCHE AG (CH) | 2024-02-29 | — | — | WO | claimed |
| CN-116151011-A | Virtual electric energy transaction simulation driven power distribution system planning method | 四川大学 | 2023-05-23 | — | — | CN | claimed |
| US-20220204631-A1 | METHODS FOR TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST | SANOFI BIOTECHNOLOGY (FR) | 2022-06-30 | — | — | US | claimed |
| CN-113411223-B | Industrial software defined network slicing method based on edge cooperation | 上海交通大学 | 2022-03-11 | — | — | CN | claimed |
| CN-1071117-C | Antitussive | TORAY INDUSTRIES (JP) | 2001-09-19 | — | — | CN | claimed |
| US-20260136963-A1 | SEMICONDUCTOR PACKAGE INCLUDING OPTICAL DEVICE PACKAGE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-05-14 | — | — | US | disclosed |
| US-20250388685-A1 | METHODS FOR TREATING CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST | SANOFI BIOTECHNOLOGY (FR) | 2025-12-25 | — | — | US | disclosed |
| EP-4666389-A1 | RECONFIGURABLE TRANSIMPEDANCE FILTER | QUALCOMM INCORPORATED (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4663250-A2 | METHODS FOR TREATING NASAL POLYPOSIS BY ADMINISTERING AN IL-4R ANTAGONIST | Sanofi Biotechnology (FR) | 2025-12-17 | — | — | EP | disclosed |
| EP-4658369-A2 | TREATMENT OF CHRONIC RHINOSINUSITIS WITH ANTI-TSLP ANTIBODY | MedImmune, LLC (US) | 2025-12-10 | — | — | EP | disclosed |
| EP-4267184-B1 | INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN | GLAXOSMITHKLINE IP DEV LTD (GB) | 2025-11-26 | — | — | EP | disclosed |
| US-8415310-B2 | Isoxazoline derivatives as antiparasitic agents | AH USA 42 LLC (US) | 2013-04-09 | — | — | US | disclosed |
| US-8410145-B2 | Insecticidal compounds | SYNGENTA CROP PROTECTION LLC (US) | 2013-04-02 | — | — | US | disclosed |
| WO-2008148849-A2 | PIPERIDINE/PIPERAZINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-12-11 | — | — | WO | disclosed |
| US-20040253636-A1 | Method of protein analysis | OXFORD GLYCOSCIENCES (UK) LTD. (GB) | 2004-12-16 | — | — | US | disclosed |
| EP-1430307-A2 | A METHOD OF PROTEIN ANALYSIS | Oxford GlycoSciences (UK) Ltd, Attn: Mary Gadsden (GB) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003027681-A2 | A METHOD OF PROTEIN ANALYSIS | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2003-04-03 | — | — | WO | disclosed |